Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Botulism Alert: ByHeart-brand infant formula linked to 13 illnesses in 10 States
-
Workers at Aimbridge-operated hotels in Los Angeles and Philadelphia strike during event-filled weekend, UNITE HERE reports
-
In Response to a Broader FDA Investigation, ByHeart Initiates a Voluntary Recall of Two Batches of Infant Formula
-
NeoPangea Expands the Future of Museum Storytelling Through Experiential Design
-
Well of Life Center Introduces Groundbreaking Non-Invasive Treatments for Incontinence, Body Sculpting, and Wellness: EMSELLA™ and EMSCULPT NEO®
-
New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting
-
Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at Amer
-
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
-
New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM
-
HBPFHoldings Shares Q3 2025 Insights on Digital Platform Analysis and Financial Investigation Trends
-
IPTV Nordic One Expands Premium Streaming Services Across Sweden and the Nordic Region
-
Monumental Milestones at the 2025 CNO Financial Indianapolis Monumental Marathon
-
Stan Taylor Launches The Black Book of Power, Calling for a Consciousness Shift as 60,000 Readers Embrace Counter-Manipulation Training
-
Level Up! Empowering the Community Through Wealth, Knowledge & Connection
-
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
-
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 202
-
Real Reaches Settlement in Principle in Litigation With Former CFO
-
Polygant Launches AI-Powered Real Estate CRM Platform for GCC Developers
-
Clearwater Wellness Launches World-First Thermoelectric Ice Bath, with Tim Paine Joining as Founding Partner
-
Louis Limited Sets New Standard for Trading Psychology With Dynamic Emotion Tracking Features
-
2026 Toy of the Year Award Finalists Unveiled at Chicago Toy & Game Fair
-
RZoasis Announces the Launch of RZUSD, a Transparent Stablecoin Amid Growing Shift Away from Centralized Alternatives
-
International Medical Relief Launches Emergency Medical Operations in Jamaica Following Hurricane Melissa
-
Sarah Maxwell Beauty and BOOKA Launch Limited "STAR Edition" Brow Mask
-
Biohm Technologies Expands Biotech R&D Footprint with New Lab Space at Portal Innovations in Atlanta
-
Devsu Recognized in the 2025 Gartner® Innovation Insight: AI-Augmented Code Modernization Tools
-
Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China
-
FIS Launches Innovative Asset Servicing Management Suite to Unlock Operational Efficiency Across Asset Servicing
-
New to The Street to Broadcast Show Number 698 on Bloomberg - Saturday, November 8, 2025, at 6:30 PM EST
-
Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Dis
-
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
-
Important Notice to Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office Is Investigating Claims on Your Behalf
-
Judo Bio’s Megalin-STRIKERs Achieve First Demonstration of Functional Pharmacodynamic Effects from Kidney Selective Gene Silencing in Non-Human Primates
-
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrol
-
Most Trusted Crypto Casinos USA: Jackbit Leads 2025 Crypto Gaming With Instant Withdrawals & No KYC Access
-
Zinzino AB (publ.): Zinzino acquires Mexican company Sanki to increase distribution capacity in North America and South America
-
Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet
-
Cindy Eckert, Founder and CEO of Sprout Pharmaceuticals, to Keynote Harvard Business School's 2025 Women's Health Summit
-
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
-
BexBack Unlocks No-KYC 100x Leverage With New $100 Bonus for Beginners
-
AMGEN'S REPATHA® CUTS RISK OF FIRST MAJOR ADVERSE CARDIOVASCULAR EVENTS BY 25% IN LANDMARK PHASE 3 VESALIUS-CV TRIAL
-
FinTex Pro Launches Fall “Fix It Right” Guarantee for Central Florida
-
Dental Crown vs. Filling: Which is Right for Me?
-
Vaughn College Hosts 11th Annual Manufacturing Day to Promote Career Opportunities and to Inspire the Next Generation of Engineering and Technology Professionals
-
Dancetime Launches Guide to Top 8 Outdoor Party Hire Essentials Amid Surge in Sydney Events
-
CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering
-
Hamail Ijaz Recognized as One of the Most Promising Young Visionary Entrepreneurs of 2025
-
Groundbreaking pivotal study results of olezarsen for severe hypertriglyceridemia (sHTG) presented as a late breaker at AHA Scientific Sessions
-
Scott Asner Shares Winter Home Maintenance Tips to Prepare for Cold Weather
-
Westinghouse and Hungary Establish Landmark Nuclear Fuel Partnership
